BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 18093720)

  • 21. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening].
    Berkers LM; van Ballegooijen M; van Kemenade FJ; Rebolj M; Essink-Bot ML; Helmerhorst TJ; Habbema JD
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1288-94. PubMed ID: 17624160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cancer screening. Past success and future challenge.
    Dewar MA; Hall K; Perchalski J
    Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases)].
    Monchy D; Lieng CR; Kruy LS; Kahler K; Eav S
    Bull Soc Pathol Exot; 2005 Sep; 98(3):183-6. PubMed ID: 16267957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The agreement between self-reported cervical smear abnormalities and screening programme records.
    Canfell K; Beral V; Green J; Cameron R; Baker K; Brown A
    J Med Screen; 2006; 13(2):72-5. PubMed ID: 16792828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
    SepĂșlveda C; Prado R
    Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved cervical cancer screening in premenopausal women by combination of Pap smear and speculoscopy.
    Twu NF; Chen YJ; Wang PH; Yu BK; Lai CR; Chao KC; Yuan CC; Yen MS
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):114-8. PubMed ID: 16797826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
    Smrkolj S; Rakar S; Mozina A; Erzen M
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of cervical carcinoma in a high-risk, non-screened area results of a retrospective analysis on the Dutch Caribbean Antilles from 1983 to 1998.
    Bax A; Voigt RR; Coronel CC; Putter H; de Bie Leuving Tjeenk RM; van Marwijk HW
    West Indian Med J; 2004 Jun; 53(3):150-4. PubMed ID: 15352742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of women treated for cervical cancer at Westmead Hospital. Implications for hospital and community-based health services.
    Wain G; Ward J; Long D
    Aust Health Rev; 1995; 18(3):111-7. PubMed ID: 10152269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of cervical cancer in women age sixty and over.
    Fox KV; Shah CA; Swisher EM; Garcia RL; Mandel LS; Gray HJ; Swensen RE; Goff BA
    Gynecol Oncol; 2008 Apr; 109(1):53-8. PubMed ID: 18255127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer screening among elderly urban women in a primary care setting.
    Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
    Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of Pap smear cytology in the Western region of Saudi Arabia.
    Jamal A; Al-Maghrabi JA
    Saudi Med J; 2003 Nov; 24(11):1225-9. PubMed ID: 14647558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of uterine cancer detected by mass screening].
    Igarashi T; Konno R; Sato S; Yajima A
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1519-26. PubMed ID: 9725043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.